Position in CYTK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$199,089
+$53,824 QoQ
Shares Held
2,337
+6.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#369
of 477 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eurizon Capital SGR S.p.A. holds $104,563,622 across 35 Biotechnology names. CYTK ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,582 | $41,020,956 | |
| 2 | INCY |
Incyte Corp
|
204,785 | $23,214,427 | |
| 3 | RPRX |
Royalty Pharma plc
|
256,636 | $14,389,580 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,467 | $9,644,293 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22,698 | $6,832,778 | |
| 6 | INSM |
INSMED Inc
|
20,247 | $2,158,735 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,985 | $1,682,710 | |
| 8 | GNTA |
Genenta Science S.p.A.
|
360,000 | $662,400 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $199,089 | 2,337 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $145,265 | 2,204 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $131,591 | 2,071 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||